What dental concern is associated with the use of Prolia?

The use of Prolia, which is a medication used primarily for the treatment of osteoporosis, has been associated with osteonecrosis of the jaw (ONJ). This condition involves the death of jawbone tissue due to a variety of factors, including a reduced blood supply to the jaw. ONJ is especially pertinent for patients undergoing treatments that affect bone metabolism and healing.

In the context of dental hygiene and patient care, it's essential to be aware of this risk, as patients on Prolia may not heal as effectively following dental procedures, extraction, or other interventions involving the jaw. Practitioners must take extra precautions and monitor these patients closely for any signs of bone issues in the jaw.

The other options listed are not commonly associated with Prolia. Increased salivation, dental hypersensitivity, and delayed tooth eruption do not have a direct link to the medication's side effects or mechanisms of action in the context of jaw health. Therefore, the focus on osteonecrosis of the jaw as a significant dental concern related to the use of Prolia is particularly important for dental health professionals to consider when caring for patients undergoing this treatment.